Health Care Presentation: Off-label Marketing of Prescription Drugs and Devices, the False Claims Act and the Impact of Medicare Part D

This presentation was authored by Mintz Levin attorney Thomas S. Crane for the American Bar Association Health Law Section Emerging Health Issues in Healthcare Law 2007, February 21 - 23, 2007.

Tom co-coordinates the firm's Health Care Fraud and Abuse and Corporate Compliance practice group. He is nationally recognized as an authority on fraud and abuse. He provides comprehensive fraud and abuse services to clients, from defense to compliance advice to compliance programs. His work in defending clients against anti-kickback, false claims, and whistleblower allegations includes litigation, internal investigations, voluntary disclosures, negotiating settlements and Corporate Integrity Agreements (CIA's). He has appeared before numerous offices of U.S. Attorneys, the FBI and OIG around the country.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »